Study of FTY720 in Patients With Uveitis

NCT01791192 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Acute Noninfectious Posterior, Intermediate, or Pan Uveitis

Interventions

DRUG: FTY720
DRUG: Oral Corticosteroid

Sponsor

Novartis Pharmaceuticals